Stem Cell Core
Stem Cell Core
批准号:
8327802
负责人:
MICHAEL Alan LAFLAMME
金额:
$25.51万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
AnimalsAttentionCanis familiarisCardiacCardiac MyocytesCardiovascular systemCause of DeathCell Culture TechniquesCell TherapyCellsChromosomesComplexConditioned Culture MediaDataDerivation procedureDevelopmentEnsureGene Transfer TechniquesGenerationsGenesGeneticGoalsHumanHuman ResourcesIn VitroIndividualMarrowMesenchymal Stem CellsMethodsModificationMyocardial InfarctionPhenotypePlasmidsPluripotent Stem CellsPreparationProductionProtocols documentationQuality ControlReporterReportingResearch PersonnelStem cellsStromal CellsSumSystemTestingTrainingTraining ProgramsTransfectionTranslatingTransplantationUndifferentiatedVascular Endothelial Growth Factor Receptor-2Workbasecell typecost effectiveembryonic stem cellexperiencehuman embryonic stem cellin vivoinduced pluripotent stem celllarge scale productionprogenitorprogramsrepairedresearch studyscale uptool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Core A: While pluripotent stem cells and their differentiated progeny have tremendous promise for cardiac
repair, their routine culture is demanding and requires considerable expertise and continuous attention to
quality control. Based on our extensive prior experience with these cells, we have found that centralization
of cell culture efforts is the best way to ensure consistency and efficiency in the large-scale production of
undifferentiated and differentiated cells. Hence, the primary goal ofthe Stem Cell Core will be to generate
large numbers of undifferentiated embryonic stem cells (ESCs), induced pluripotent stem cells (iPSCs),
mesenchymal stem cells (MSCs) and cardiac derivatives for distribution to the individual projects in this
program. The Core will also work closely with investigators in Project 2 to optimize the derivation of
cardiomyocytes from canine ESCs. Finally, the Core will also develop and share optimized protocols for the
genetic modification of ESCs and iPSCs, including the generation of cell type specific reporter lines via
transgenesis in bacterial artficial chromosomes (BACs). In sum, the Core will undertake three specific aims:
1) to provide the individual projects with the stem cells and cardiac derivatives needed to complete their
respective aims, 2) to develop BAC transgenesis and optimize the delivery of modified BACs into human
ESCs and iPSCs), and 3) to provide training and technical assistance with in vitro experiments involving
pluripotent stem cells or their differentiated progeny.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Integration and Arrhythmia Suppression with hESC-Derived Cardiomyocyte Grafts
-
批准号:8701393
-
项目类别:
-
资助金额:$41.69万
-
财政年份:2013
-
负责人:MICHAEL Alan LAFLAMME
-
依托单位:
Integration and Arrhythmia Suppression with hESC-Derived Cardiomyocyte Grafts
-
批准号:8477849
-
项目类别:
-
资助金额:$41.09万
-
财政年份:2013
-
负责人:MICHAEL Alan LAFLAMME
-
依托单位:
Subtype Spec.& Arrhythmogenica Potential of Stem Cell Derived Cardiomyocytes
-
批准号:7806060
-
项目类别:
-
资助金额:$51.8万
-
财政年份:2010
-
负责人:MICHAEL Alan LAFLAMME
-
依托单位:
Stem Cell Core
-
批准号:7806064
-
项目类别:
-
资助金额:$28.61万
-
财政年份:2010
-
负责人:MICHAEL Alan LAFLAMME
-
依托单位:
Myocardium and Conduction System from ESCs
-
批准号:7060437
-
项目类别:
-
资助金额:$12.56万
-
财政年份:2005
-
负责人:MICHAEL Alan LAFLAMME
-
依托单位:
Myocardium and Conduction System from ESCs
-
批准号:7364547
-
项目类别:
-
资助金额:$12.56万
-
财政年份:2005
-
负责人:MICHAEL Alan LAFLAMME
-
依托单位:
Myocardium and Conduction System from ESCs
-
批准号:7190577
-
项目类别:
-
资助金额:$12.56万
-
财政年份:2005
-
负责人:MICHAEL Alan LAFLAMME
-
依托单位:
Myocardium and Conduction System from ESCs
-
批准号:6909658
-
项目类别:
-
资助金额:$12.56万
-
财政年份:2005
-
负责人:MICHAEL Alan LAFLAMME
-
依托单位:
Myocardium and Conduction System from ESCs
-
批准号:7643446
-
项目类别:
-
资助金额:$12.56万
-
财政年份:2005
-
负责人:MICHAEL Alan LAFLAMME
-
依托单位:
Subtype Spec.& Arrhythmogenica Potential of Stem Cell Derived Cardiomyocytes
-
批准号:8485642
-
项目类别:
-
资助金额:$49.44万
-
财政年份:--
-
负责人:MICHAEL Alan LAFLAMME
-
依托单位:
Subtype Spec.& Arrhythmogenica Potential of Stem Cell Derived Cardiomyocytes
-
批准号:8676868
-
项目类别:
-
资助金额:$29.07万
-
财政年份:--
-
负责人:MICHAEL Alan LAFLAMME
-
依托单位:
Stem Cell Core
-
批准号:8676870
-
项目类别:
-
资助金额:$64.65万
-
财政年份:--
-
负责人:MICHAEL Alan LAFLAMME
-
依托单位:
Stem Cell Core
-
批准号:8380425
-
项目类别:
-
资助金额:$30.01万
-
财政年份:--
-
负责人:MICHAEL Alan LAFLAMME
-
依托单位:
Subtype Spec.& Arrhythmogenica Potential of Stem Cell Derived Cardiomyocytes
-
批准号:8327800
-
项目类别:
-
资助金额:$51.58万
-
财政年份:--
-
负责人:MICHAEL Alan LAFLAMME
-
依托单位:
Subtype Spec.& Arrhythmogenica Potential of Stem Cell Derived Cardiomyocytes
-
批准号:8380421
-
项目类别:
-
资助金额:$51.46万
-
财政年份:--
-
负责人:MICHAEL Alan LAFLAMME
-
依托单位:
Stem Cell Core
-
批准号:8485644
-
项目类别:
-
资助金额:$27.99万
-
财政年份:--
-
负责人:MICHAEL Alan LAFLAMME
-
依托单位:
国内基金
海外基金
多模态超声VisTran-Attention网络评估早期子宫颈癌保留生育功能手术可行性
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:郑巧
-
依托单位:
Ultrasomics-Attention孪生网络早期精准评估肝内胆管癌免疫治疗的研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:陈立达
-
依托单位: